These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8120707)

  • 21. A neuropsychological profile of off-diet adults with phenylketonuria.
    Moyle JJ; Fox AM; Bynevelt M; Arthur M; Burnett JR
    J Clin Exp Neuropsychol; 2007 May; 29(4):436-41. PubMed ID: 17497567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory control in children with phenylketonuria.
    Christ SE; Steiner RD; Grange DK; Abrams RA; White DA
    Dev Neuropsychol; 2006; 30(3):845-64. PubMed ID: 17083296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.
    Smith I; Lobascher ME; Stevenson JE; Wolff OH; Schmidt H; Grubel-Kaiser S; Bickel H
    Br Med J; 1978 Sep; 2(6139):723-6. PubMed ID: 698696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.
    Smith I; Beasley MG; Ades AE
    Arch Dis Child; 1991 Mar; 66(3):311-6. PubMed ID: 2025007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. School performance and intellectual outcome in adolescents with phenylketonuria.
    Weglage J; Fünders B; Wilken B; Schubert D; Ullrich K
    Acta Paediatr; 1993; 82(6-7):582-6. PubMed ID: 8338995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social quotients of children with phenylketonuria before and after discontinuation of dietary therapy.
    Matthews WS; Barabas G; Cusack E; Ferrari M
    Am J Ment Defic; 1986 Jul; 91(1):92-4. PubMed ID: 3740120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of phenylketonuria: wish and reality].
    Weglage J; Fünders B; Wilken B; van Teeffelen-Heithoff A; Ullrich K
    Monatsschr Kinderheilkd; 1993 Aug; 141(8):670-4. PubMed ID: 8377773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of intelligence test results in treated phenylketonuric children.
    Williamson ML; Koch R; Azen C; Chang C
    Pediatrics; 1981 Aug; 68(2):161-7. PubMed ID: 7267221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971.
    Beasley MG; Costello PM; Smith I
    Q J Med; 1994 Mar; 87(3):155-60. PubMed ID: 8208903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intelligence and behaviour in children with early treated phenylketonuria. A report from the MRC/DHSS phenylketonuria register.
    Smith I; Beasley M
    Eur J Clin Nutr; 1989; 43 Suppl 1():1-5. PubMed ID: 2737171
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of dietary non-compliance on development in phenylketonuria--studies of 14-year-old patients].
    Theile H; Graustein I; Wässer S; Bührdel P
    Padiatr Padol; 1990; 25(1):19-23. PubMed ID: 2326088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wechsler subscale IQ and subtest profile in early treated phenylketonuria.
    Griffiths PV; Demellweek C; Fay N; Robinson PH; Davidson DC
    Arch Dis Child; 2000 Mar; 82(3):209-15. PubMed ID: 10685922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
    Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
    Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult phenylketonuria.
    Hanley WB
    Am J Med; 2004 Oct; 117(8):590-5. PubMed ID: 15465508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intelligence of phenylketonuria patients treated early; 10-year psychological follow-up in the Netherlands].
    Huisman J; Slijper FM; Hendrikx MM; Kalverboer AF; van der Schot L
    Ned Tijdschr Geneeskd; 1985 Nov; 129(44):2120-3. PubMed ID: 4079998
    [No Abstract]   [Full Text] [Related]  

  • 39. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between biochemical-biological parameters and intellectual development in treated phenylketonuria children].
    Cobet G; Witkowski R
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():269-75. PubMed ID: 7157122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.